Platelet potential to switch to procoagulant phenotype compensates bleeding tendency in patients with hemophilia A

Platelet potential to switch to procoagulant phenotype compensates bleeding tendency in patients with hemophilia A

Saved in:

Bibliographic Details
Main Authors:	Karina Althaus, Sophie Kieninger, Anna Bäuerle, Stefanie Hammer, Nina Wolska, Günalp Uzun, Karoline Weich, Lorenzo Alberio, Alessandro Aliotta, Christoph Faul, Margarete Moyses, Ursula Holzer, Vanya Icheva, David Gorodezki, Sebastian Hörber, Susan Halimeh, Jan Zlamal, Tamam Bakchoul
Format:	Article
Language:	English
Published:	Elsevier 2025-03-01
Series:	Blood Advances
Online Access:	http://www.sciencedirect.com/science/article/pii/S247395292500014X
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hematopoietic stem cell transplantation in a newborn suffering from severe combined immunodeficiency and severe hemophilia A: a case report and review of the literature
by: Sarah Schober, et al.
Published: (2025-03-01)

Procoagulant and Anticoagulant Factors in Childhood Hypothyroidism
by: Nevin Kilic, et al.
Published: (2012-01-01)

Procoagulant constituents from Cordyceps militaris
by: Juanjuan Zhang, et al.
Published: (2018-12-01)

Platelet spleen tyrosine kinase is a key regulator of anti-PF4 antibody–induced immunothrombosis
by: Jan Zlamal, et al.
Published: (2025-04-01)

Lipid signatures of immunothrombosis: insights from VITT
by: Tamam Bakchoul, et al.
Published: (2025-02-01)

Expression of Procoagulant Microparticles Assessed by Thrombin Generation Test in Cirrhosis
by: Mejda Belakremi MD, et al.
Published: (2025-07-01)

The Procoagulant and Fibrinolytic Balance of Extracellular Vesicles Predicts Mortality in Septic Shock Patients
by: Romaric Lacroix, et al.
Published: (2025-06-01)

Aspirin modulates generation of procoagulant phospholipids in cardiovascular disease, by regulating LPCAT3
by: Majd B. Protty, et al.
Published: (2025-01-01)

Converging Molecular Mechanisms of Nucleated Cell Death Pathways and Procoagulant Platelet Formation
by: Cong Li, et al.
Published: (2025-07-01)

CO46 | Comparison of reticulated platelet procoagulant role in liver cirrhosis vs. fibrosis
Published: (2025-08-01)

Possible cause of clot in hematopoietic progenitor cell product: Procoagulant activity or inadequate anticoagulation?
by: Shubham Gupta, et al.
Published: (2024-12-01)

Effect of plasma levels of factor VIII according to procoagulant phospholipids on the risk of future venous thromboembolism
by: Magnus S. Edvardsen, et al.
Published: (2025-01-01)

Procoagulant effect of phosphatidylserine-exposed blood cells, endothelial cells and extracellular vesicles in patients with aortic stenosis
by: Haiyang Wang, et al.
Published: (2025-06-01)

Neutrophil Extracellular Traps Enhance Procoagulant Activity and Predict Poor Prognosis in Patients With Metastatic Breast Cancer
by: Gong Y, et al.
Published: (2025-03-01)

High risk oral contraceptive hormones do not directly enhance endothelial cell procoagulant activity in vitro.
by: Emma G Bouck, et al.
Published: (2023-01-01)

Procoagulant, tissue factor-bearing microparticles in bronchoalveolar lavage of interstitial lung disease patients: an observational study.
by: Federica Novelli, et al.
Published: (2014-01-01)

MYOCARDIAL INFARCTION AND HEMOPHILIA
by: A. S. Galyavich, et al.
Published: (2016-03-01)

MANAGEMENT OF INHIBITORS IN HEMOPHILIA
by: Gaye Kalacı Katayıfçı
Published: (2024-12-01)

HEMOPHILIA: ADVANCES IN TREATMENTS
by: Nurgül Karakaya
Published: (2024-12-01)

New Treatment Modalities in Hemophilia
by: Kaan Kavaklı
Published: (2022-03-01)

Clinical case of an acquired hemophilia
by: P. N. Barlamov, et al.
Published: (2020-01-01)

Gene-based therapies for hemophilia
by: Melissa F. Glasner, et al.
Published: (2025-05-01)

Hemophilia treatments and the paradox of choice
by: Mike Makris, et al.
Published: (2025-02-01)

Evaluation of the Effect of Phase 1 Periodontal Therapy on Serum Procoagulant State of Systemically Healthy Chronic Periodontitis Subjects: A Clinico-Biochemical Study
by: Sapna Raje, et al.
Published: (2025-06-01)

FDA APPROVES NEW HEMOPHILIA DRUG
by: article Editorial
Published: (2025-02-01)

Hemophilia is associated with accelerated biological aging
by: Marina Trappl, et al.
Published: (2025-03-01)

Marstacimab for the Treatment of Hemophilia A or B
by: Mahlangu J
Published: (2025-06-01)

Platelets as Modifiers of Clinical Phenotype in Hemophilia
by: Donald L. Yee
Published: (2006-01-01)

General Considerations on Clinical Trials of Hemophilia Medicines
by: Zh. I. Avdeeva, et al.
Published: (2020-03-01)

Management of Acquired Hemophilia A in Elderly Patients
by: Tomoya Yamaguchi, et al.
Published: (2018-01-01)

Acquired Hemophilia Developing After Whipple Operation
by: Nebi Acar, et al.
Published: (2025-04-01)

Rebalancing agents in hemophilia: knowns, unknowns, and uncertainties
by: Quentin Van Thillo, et al.
Published: (2025-07-01)

Guidelines for management of hemophilia—why, what, and how?
by: Alok Srivastava, et al.
Published: (2025-05-01)

Psychological Factors that Influence the Health of People with Hemophilia
by: Luis Horacio Aguiar Palacios, et al.
Published: (2025-06-01)

Acquired (autoimmune) hemophilia: demographics, outcomes, and readmissions
by: Aditi Sharma, et al.
Published: (2025-05-01)

Getting closer to hemophilia gene therapy for all?
by: Ulrike M. Reiss
Published: (2025-07-01)

“Bridegroom of blood”- A biblical reference to hemophilia?
by: Joshua M. Kosowsky
Published: (2025-07-01)

Acquired Hemophilia A successfully treated with rituximab
by: Giovanni D'Arena, et al.
Published: (2015-02-01)

Investigation of SEN virus prevalence in hemophilia patients
by: Davod Javanmard, et al.
Published: (2024-12-01)

Airway compromise in a patient with hemophilia A
by: Megan E. McLin‐Evans, et al.
Published: (2024-02-01)